Literature DB >> 16164629

Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells.

Uta Kunter1, Soizic Daniel, Maria B Arvelo, Jean Choi, Tala Shukri, Virendra I Patel, Christopher R Longo, Salvatore T Scali, Gautam Shrikhande, Eduardo Rocha, Eva Czismadia, Christina Mottley, Shane T Grey, Jürgen Floege, Christiane Ferran.   

Abstract

BACKGROUND: Apoptotic death of renal proximal tubular epithelial cells (RPTECs) is a feature of acute and chronic renal failure. RPTECs are directly damaged by ischemia, inflammatory, and cytotoxic mediators but also contribute to their own demise by up-regulating proinflammatory nuclear factor-kappaB (NF-kappaB)-dependent proteins. In endothelial cells, the Bcl family member A1 and the zinc finger protein A20 have redundant and dual antiapoptotic and anti-inflammatory effects. We studied the function(s) of A1 and A20 in human RPTECs in vitro.
METHODS: Expression of A1 [reverse transcription-polymerase chain reaction (RT-PCR) and A20 (Northern and Western blot analysis)] in RPTECs was evaluated. A1 and A20 were overexpressed in RPTECs by recombinant adenoviral-mediated gene transfer. Their effect upon inhibitor of NFkappaB alpha (IkappaBalpha) degradation (Western blot), NF-kappaB nuclear translocation [electrophoretic mobility shift assay (EMSA)], up-regulation of intercellular adhesion molecule-1 (ICAM-1) [fluorescence-activated cell sorter (FACS)] and monocyte chemoattractant protein-1 (MCP-1) (Northern blot) and apoptosis [terminal deoxynucleotiddyl transferase (TdT)-mediated deoxyuridine triphosphate (dUTP) nick-end labeling (TUNEL)] and FACS analysis of DNA content) was determined.
RESULTS: A1 and A20 were induced in RPTECs as part of the physiologic response to tumor necrosis factor (TNF). A20, but not A1, inhibited TNF-induced NF-kappaB activation by preventing IkappaBalpha degradation, hence subsequent up-regulation of the proinflammatory molecules ICAM-1 and MCP-1. Unexpectedly, A20 did not protect RPTECs from TNF and Fas-mediated apoptosis while A1 protected against both stimuli. Coexpression of A1 and A20 in RPTECs achieved additive anti-inflammatory and antiapoptotic cytoprotection.
CONCLUSION: A1 and A20 exert differential cytoprotective effects in RPTECs. A1 is antiapoptotic. A20 is anti-inflammatory via blockade of NF-kappaB. We propose that A1 and A20 are both required for optimal protection of RPTECs from apoptosis (A1) and inflammation (A20) in conditions leading to renal damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16164629     DOI: 10.1111/j.1523-1755.2005.00564.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  17 in total

Review 1.  Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.

Authors:  Chandra Mohan; Chaim Putterman
Journal:  Nat Rev Nephrol       Date:  2015-03-31       Impact factor: 28.314

2.  Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation.

Authors:  Cleide G da Silva; Elizabeth R Maccariello; Szuhuei Wu Wilson; Prabhakar Putheti; Soizic Daniel; Scott M Damrauer; Clayton R Peterson; Jeffrey J Siracuse; Elzbieta Kaczmarek; Christiane Ferran
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

3.  Cubilin-, megalin-, and Dab2-dependent transcription revealed by CRISPR/Cas9 knockout in kidney proximal tubule cells.

Authors:  Kimberly R Long; Youssef Rbaibi; Corry D Bondi; B Rhodes Ford; Amanda C Poholek; Cary R Boyd-Shiwarski; Roderick J Tan; Joseph D Locker; Ora A Weisz
Journal:  Am J Physiol Renal Physiol       Date:  2021-11-08

4.  The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation.

Authors:  Jens Lutz; Le A Luong; Matthias Strobl; Meihong Deng; Hai Huang; Martina Anton; Mustafa Zakkar; Karine Enesa; Hera Chaudhury; Dorian O Haskard; Marcus Baumann; Joseph Boyle; Sarah Harten; Patrick H Maxwell; Charles Pusey; Uwe Heemann; Paul C Evans
Journal:  J Mol Med (Berl)       Date:  2008-09-24       Impact factor: 4.599

5.  The C-terminal domain of A1/Bfl-1 regulates its anti-inflammatory function in human endothelial cells.

Authors:  Renata P Guedes; Eduardo Rocha; Jerome Mahiou; Herwig P Moll; Maria B Arvelo; Janis M Taube; Clayton R Peterson; Elzbieta Kaczmarek; Christopher R Longo; Cleide G da Silva; Christiane Ferran
Journal:  Biochim Biophys Acta       Date:  2013-03-13

6.  Constitutive expression of the anti-apoptotic Bcl-2 family member A1 in murine endothelial cells leads to transplant tolerance.

Authors:  L A Smyth; L Meader; F Xiao; M Woodward; H J M Brady; R Lechler; G Lombardi
Journal:  Clin Exp Immunol       Date:  2017-03-02       Impact factor: 4.330

7.  A20 modulates lipid metabolism and energy production to promote liver regeneration.

Authors:  Scott M Damrauer; Peter Studer; Cleide G da Silva; Christopher R Longo; Haley E Ramsey; Eva Csizmadia; Gautam V Shrikhande; Salvatore T Scali; Towia A Libermann; Manoj K Bhasin; Christiane Ferran
Journal:  PLoS One       Date:  2011-03-17       Impact factor: 3.240

8.  TNFα Amplifies DNaseI Expression in Renal Tubular Cells while IL-1β Promotes Nuclear DNaseI Translocation in an Endonuclease-Inactive Form.

Authors:  Dhivya Thiyagarajan; Ole Petter Rekvig; Natalya Seredkina
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

9.  Pattern-recognition receptor signaling regulator mRNA expression in humans and mice, and in transient inflammation or progressive fibrosis.

Authors:  Roman Günthner; Vankayala Ramaiah Santhosh Kumar; Georg Lorenz; Hans-Joachim Anders; Maciej Lech
Journal:  Int J Mol Sci       Date:  2013-09-04       Impact factor: 5.923

10.  Impact of anti-inflammatory agents on the gene expression profile of stimulated human neutrophils: unraveling endogenous resolution pathways.

Authors:  Mireille St-Onge; Aline Dumas; Annick Michaud; Cynthia Laflamme; Andrée-Anne Dussault; Marc Pouliot
Journal:  PLoS One       Date:  2009-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.